NDC 0143-9245

Dacarbazine

Dacarbazine

Dacarbazine is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Dacarbazine.

Product ID0143-9245_aac851c5-8ca2-4b13-87cb-f8f78b1f2cbc
NDC0143-9245
Product TypeHuman Prescription Drug
Proprietary NameDacarbazine
Generic NameDacarbazine
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2001-08-08
Marketing CategoryANDA / ANDA
Application NumberANDA075812
Labeler NameHikma Pharmaceuticals USA Inc.
Substance NameDACARBAZINE
Active Ingredient Strength10 mg/mL
Pharm ClassesAlkylating Activity [MoA],Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0143-9245-10

10 VIAL in 1 CARTON (0143-9245-10) > 20 mL in 1 VIAL (0143-9245-01)
Marketing Start Date2001-08-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0143-9245-01 [00143924501]

Dacarbazine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA075812
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2001-08-08

NDC 0143-9245-10 [00143924510]

Dacarbazine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA075812
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2001-08-08

Drug Details

NDC Crossover Matching brand name "Dacarbazine" or generic name "Dacarbazine"

NDCBrand NameGeneric Name
0143-9245DacarbazineDacarbazine
0703-5075DacarbazineDacarbazine
61703-327DacarbazineDACARBAZINE
63323-127DacarbazineDACARBAZINE
63323-128DacarbazineDACARBAZINE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.